原发性肝癌综合治疗282例分析

Clinic analysis of combine treatment to 282 cases of primary hepatic cancer

本文报告１９８０年６月至１９９４年１０月治疗中晚期原发性肝癌２８２例，男２３８例，女４４例，年龄１７～７６岁，结节型肝癌１３０例，巨块型肝癌９２例，弥漫型肝癌６０例，其中自发性破裂大出血２１例，全部病例经Ｂ超显像，ＣＴ扫描，肝动脉造影，ＡＦＰ测定及病理组织学检查确诊。外科手术治疗９４例，其中脉叶切除３０例，半年、１年、２年、３年、５年生存率为７９．９％，５６．０％。２２．７％１３．６．和１０．０％；行肝动脉血流阻断为主的外科综合治疗６０例，半年，１年、２年生存率为７８．３％，５２．４％，１３．８％；手术探查４例，存活期均少于４个月。对不能切除的中晚期肝癌行介入栓塞治疗１８８例，半年、１年、２年、３年生存率为７３．４％，３８．８％，１９．７％和６．７％。

We had reviewed 282 cases of primary hepatic cancer (PHC) patients in the meddle-Late period,treated during June 1980 and october 1994,in cluding 130 cases of nodular PHC, 92 cases of the massive,60 cases of the diffuse and 21 casese of ruptured PHC, 94 patients had been operated,there were 30 cases of hepatic lobectomy withe 0. 5-, 1-, 2-, 3-and 5-year survival rates were respectively 79.9%,56. 0%,22.7%, 13. 6% and 10. 0%. Hepatic dearterializations were taken in 60 cases combining with other surgical treatment with the 0.5-,1-,2-year survival rates cuers 78.3%,52. 4%,and 13. 8%, Explorative operations had done in 4 patients with the survival time shorter than 4 months, 188patients who were unresectable, were treated by hepatic arterial embolization and infusion of drugs with the 0. 5-, 1-, 2-,and 3-year survival rates were 73. 4%, 38. 8%, 19. 7% and 6. 7%